Published Date:2024-05-21 Original Link:https://www.onenessbio.com/en/news_detail290_3.htm No 2 Date of announcement 2024/05/21 Time of announcement 17:41:48 Subject Oneness announce re-election of all directors in the 2024 Annual General Shareholders’ Meeting. To which item it meets paragraph 6 Date of events 2024/05/21 Statement Date of occurrence of the change: 2024/05/21 Elected or changed position (Please enter institutional director,...Read More
Published Date:2024-05-21 Original Link:https://www.onenessbio.com/en/news_detail289_3.htm No 1 Date of announcement 2024/05/21 Time of announcement 17:30:28 Subject Oneness announce the important resolutions of the 2024 Annual General Shareholders’ Meeting To which item it meets paragraph 18 Date of events 2024/05/21 Statement Date of the shareholders’ meeting: 2024/05/21 Important resolutions I.Profit distribution/deficit compensation: Approved the 2023 deficit compensation...Read More
Published Date:2024-05-17 Original Link:https://www.onenessbio.com/en/news_detail288_3.htm No 1 Date of announcement 2024/05/17 Time of announcement 10:08:58 Subject According to U.S. FDA’s suggestion, the company agrees to withdraw the 510(k) for Bonvadis chronic wound and resubmit after the supplementing animal study data. To which item it meets paragraph 10 Date of events 2024/05/16 Statement Date of occurrence of...Read More
Published Date:2024-05-13 Original Link:https://www.onenessbio.com/en/news_detail287_3.htm No 3 Date of announcement 2024/05/13 Time of announcement 17:09:59 Subject The Company’s 2024Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2024/05/13 Statement Date of the board of directors submitted or approved: 2024/05/13 Date of the audit...Read More
Published Date:2024-05-13 Original Link:https://www.onenessbio.com/en/news_detail286_3.htm No 2 Date of announcement 2024/05/13 Time of announcement 16:59:51 Subject The board of directors of the Company approved removal of the noncompete clause for managers. To which item it meets paragraph 21 Date of events 2024/05/13 Statement Date of the board of directors resolution: 2024/05/13 Name and title of the...Read More
Published Date:2024-05-13 Original Link:https://www.onenessbio.com/en/news_detail285_4.htm No 1 Date of announcement 2024/05/13 Time of announcement 16:53:53 Subject The Board of Directors approved the amendment of 2023 Restricted Stock Awards Issuance Rules To which item it meets paragraph 11 Date of events 2024/05/13 Statement Date of occurrence of the event: 2024/05/13 Date of the original announcement and reporting:...Read More
Published Date:2024-05-09 Original Link:https://www.onenessbio.com/en/news_detail284_4.htm No 1 Date of announcement 2024/05/09 Time of announcement 17:52:36 Subject S.C. injection formulation of FB825 has been agreed by US FDA to proceed with Phase 2 clinical trial to treat moderate-to-severe atopic dermatitis. To which item it meets paragraph 10 Date of events 2024/05/09 Statement Date of occurrence of the...Read More
Published Date:2024-05-03 Original Link:https://www.onenessbio.com/en/news_detail282_4.htm No 1 Date of announcement 2024/05/03 Time of announcement 17:15:55 Subject Announcement the Company’s board of directors meeting date of the First Quarter of 2024 Consolidated Financial Reports To which item it meets paragraph 31 Date of events 2024/05/03 Statement Date of a notice of the board of directors meeting is...Read More
Published Date:2024-05-02 Original Link:https://www.onenessbio.com/en/news_detail281_4.htm No 1 Date of announcement 2024/05/02 Time of announcement 17:53:51 Subject Oneness Biotech Co., Ltd. receives a Japanese patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/05/02 Statement Date of occurrence of the event: 2024/05/02...Read More
